Enveda (Series B)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$234,999,998
Company Info
Founders
Viswa Colluru
Market
Healthcare & Wellness
Coinvestors
Jazz Ventures,Hummingbird Ventures,True Ventures,Lux Capital
Company Description

A biotech harnessing the power of nature’s chemistry to develop next-gen small molecule therapeutics. Enveda Biosciences is a biotechnology company engineering new drugs from plants.